Skip to main content
Myriad Genetics, Inc. (LON:0K3W)
London flag London · Delayed Price · Currency is GBP · Price in USD
14.72
+0.50 (3.54%)
At close: Feb 19, 2025

Myriad Genetics Revenue

Myriad Genetics had revenue of $213.30M USD in the quarter ending September 30, 2024, with 11.15% growth. This brings the company's revenue in the last twelve months to $823.60M, up 12.15% year-over-year. In the year 2023, Myriad Genetics had annual revenue of $753.20M with 11.03% growth.

Revenue (ttm)
$823.60M
Revenue Growth
+12.15%
P/S Ratio
n/a
Revenue / Employee
$305.04K
Employees
2,700
Market Cap
1.02B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023753.20M74.80M11.03%
Dec 31, 2022678.40M-12.20M-1.77%
Dec 31, 2021690.60M133.60M23.99%
Dec 31, 2020557.00M-81.60M-12.78%
Jun 30, 2020638.60M-212.50M-24.97%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
GSK plc 31.38B
Haleon 11.24B
Smith & Nephew 4.46B
Hikma Pharmaceuticals 2.39B
ConvaTec Group 1.74B
HUTCHMED (China) 483.31M
Genus 668.80M
Revenue Rankings

Myriad Genetics News

More News